ORO Labs Celebrates Remarkable Ranking in 2026 Inc. 5000 List
ORO Labs, an industry leader in procurement orchestration for global enterprises, proudly announced that it has secured the
92nd spot on the prestigious
2026 Inc. 5000 list. This annual list ranks the fastest-growing private companies in America and is recognized as a benchmark for entrepreneurial excellence. Being featured alongside notable companies such as Microsoft, Meta, Chobani, and Oracle, ORO Labs' position as
No. 8 among software companies showcases its significant impact within the sector.
Growing Demand for Procurement Solutions
The Co-Founder and CEO of ORO Labs,
Sudhir Bhojwani, articulated the complexities faced in procurement workflows. He stated, "The hardest part of procurement happens after a request comes in, when it must navigate varied systems, approvals, and controls." He emphasized the necessity for advanced AI systems capable of managing complex procurement processes effectively while adhering to company guidelines. This spotlight on the operational complexity has translated into
300% revenue growth in the last year alone.
Innovative Platform Streamlining Operations
ORO’s innovative, no-code platform orchestrates various tasks across the workflow spectrum—including intake, sourcing, supplier management, risk, compliance, and finance. This seamless integration connects personnel, systems, and AI agents, enabling each request to progress through a controlled, auditable process from initiation to execution. Over the past year, the company has significantly expanded its offerings, introducing over
65 preconfigured agents and enhancing capabilities in sourcing, contract orchestration, and supplier engagement.
Moreover, clients using ORO's
AI Agent Builder have seen operations streamline dramatically. Reports indicate reductions in onboarding cycles of up to
80% and a staggering
75% fewer manual reviews. These enhancements not only reflect ORO's commitment to optimizing procurement efficiency but also signify a broader trend in the industry’s digitization and automation efforts.
Major Milestones and Recognition
In March 2026, ORO Labs announced a
$100 million Series C funding round, aimed at accelerating the widespread adoption of its agentic orchestration solutions across enterprise procurement and finance functions. The platform now boasts deployment in over
100 countries, underscoring its international reach and significance in the market.
Additionally, ORO has set a remarkable precedent by being the first company to earn the title of
Top Procurement Technology Provider in successive years at the
World Procurement Awards. This recognition, alongside being named an
ISM Supply Chain Trailblazer, reaffirms the company’s leading position in the supply chain sector.
Impact of the 2026 Inc. 5000
The
2026 Inc. 5000 highlights a new cohort of companies redefining growth through innovation and entrepreneurial spirit. This year’s list indicates a median three-year revenue growth rate of
130%, with honorees collectively adding more than
627,208 jobs to the U.S. economy over the past three years. As stated by
Mike Hofman, editor-in-chief of Inc., the growth exhibited by these companies goes beyond financial gains; it is a testament to creativity, resilience, and a strong dedication to customer satisfaction.
Each company featured on the list showcases a unique story marked by perseverance and the determination to drive forward despite challenges.
For more information on ORO Labs’ innovative solutions and to explore the complete Inc. 5000 list, you can visit
Inc. 5000 website.
About ORO Labs
Founded by
former SAP Ariba product leaders, ORO Labs is on a mission to simplify and enhance the procurement process for enterprises globally. By delivering effortless user experiences that shorten cycle times while reducing risks, ORO Labs empowers Fortune 500 companies and rapid-growth leaders to reinvent processes and elevate their procurement strategies from idea to pay. The platform has gained the trust of leading global brands, including
The Coca-Cola Company, Pfizer, and Danone, to maximize their procurement potential.